Racialized Adolescents, Mental Health Promotion and the Role of Spiritual Youth Leaders

Summary

This study explores how spiritual youth leaders promote mental health for racialized youth. Adolescents in racial and ethnic minority groups are a growing population in Canada. Their mental health is of concern as they are in a critical stage of development. Research shows religion and spirituality can play a key role in youth upbringing. There is research studying spirituality, mental health, and racialized adolescents. But, few studies are tackling the three topics at the same time. This study seeks to add to research on mental health interventions for adolescents. This project will apply a qualitative approach. The researcher will interview youth leaders. These leaders are part of Christian churches with communities of racial and ethnic minorities. This may help implementation of interventions to strengthen youth well-being.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 29

Accepts healthy participants: Yes

Inclusion criteria:

You are eligible to participate if you meet all of the following criteria: the participant must be (i) currently volunteering or working as a youth leader at a Christian church (ii) regularly interacting with racialized adolescents, (iii) 18 or older, and (iv) has the autonomy to give informed and personal consent.

Exclusion criteria:

You are not eligible to participate if you are 1) under the age of 18. 2) cannot give informed and personal consent.

Participate

Fill out the following form if you want to participate in this research

Method of contact

Collection of personal information
Your personal information is collected under the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If you have any questions about the collection or use of this information, please visit our Access to Information page.

Additional information

Contact information

Researcher Email address: christopher.jost@ucalgary.ca Phone number: 403-926-9309

Principal investigator:

Ajwang' Roseline WARRIA

Clinical trial:

No

REB-ID:

REB24-0613